Considering that RUNX3 is frequently overexpressed in AML, we next examined the impact of RUNX3 overexpression on myeloid development by transducing normal human CD34+ HSPC with recombinant retrovirus co-expressing RUNX3 and DsRed. Here, RUNX3 is linked to acute myeloid leukemia.